Lindsey Rolfe

2018

In 2018, Lindsey Rolfe earned a total compensation of $1.8M as EVP of Clinical and Development and Pharmacovigilance and Chief Medical Officer at Clovis Oncology, a 25% decrease compared to previous year.

Compensation breakdown

Bonus$195,720
Option Awards$474,240
Salary$486,505
Stock Awards$642,730
Other$19,816
Total$1,819,011

Rolfe received $642.7K in stock awards, accounting for 35% of the total pay in 2018.

Rolfe also received $195.7K in bonus, $474.2K in option awards, $486.5K in salary and $19.8K in other compensation.

Rankings

In 2018, Lindsey Rolfe's compensation ranked 6,211th out of 14,244 executives tracked by ExecPay. In other words, Rolfe earned more than 56.4% of executives.

ClassificationRankingPercentile
All
6,211
out of 14,244
56th
Division
Manufacturing
2,376
out of 5,759
59th
Major group
Chemicals And Allied Products
887
out of 2,122
58th
Industry group
Drugs
743
out of 1,811
59th
Industry
Pharmaceutical Preparations
579
out of 1,385
58th

Pay ratio

Lindsey Rolfe's Pay$1,819,011
Median Employee's Pay$349,809
Pay Ratio

5

to 1

In 2018, the annual total compensation of Lindsey Rolfe was $1,819,011.

The annual total compensation of the median employee at Clovis Oncology was $349,809.

The ratio of Lindsey Rolfe's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 26, 2019.

Rolfe's colleagues

We found four more compensation records of executives who worked with Lindsey Rolfe at Clovis Oncology in 2018.

2018

Patrick Mahaffy

Clovis Oncology

Chief Executive Officer

2018

Gillian Ivers-Read

Clovis Oncology

EVP and Chief Regulatory Officer

2018

C Hooks

Clovis Oncology

Former Senior VP and Chief Commercial Officer

2018

Daniel Muehl

Clovis Oncology

Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer

News

You may also like